Methods to reduce the risk of cardiovascular events in patients on statin therapy

摘要

In various embodiments, the present invention provides a method of reducing the risk of cardiovascular events in a subject undergoing statin therapy, specifically a fasting baseline of about 135 mg / dL to about 500 mg / dL. Methods for reducing the risk of cardiovascular events in a subject undergoing statin therapy having triglyceride levels and administering to the subject a pharmaceutical composition comprising about 1 g to about 4 g of eicosapentaenoic acid ethyl ester or a derivative thereof I will provide a. [Selection figure] None